WO2002062984A1 - The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof - Google Patents
The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof Download PDFInfo
- Publication number
- WO2002062984A1 WO2002062984A1 PCT/CN2001/000117 CN0100117W WO02062984A1 WO 2002062984 A1 WO2002062984 A1 WO 2002062984A1 CN 0100117 W CN0100117 W CN 0100117W WO 02062984 A1 WO02062984 A1 WO 02062984A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell
- yeast
- biological preparations
- specific
- immonological
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2001/000117 WO2002062984A1 (en) | 2001-02-08 | 2001-02-08 | The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2001/000117 WO2002062984A1 (en) | 2001-02-08 | 2001-02-08 | The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002062984A1 true WO2002062984A1 (en) | 2002-08-15 |
Family
ID=4574771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2001/000117 WO2002062984A1 (en) | 2001-02-08 | 2001-02-08 | The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2002062984A1 (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1375652A3 (en) * | 2002-06-28 | 2004-01-07 | Ultra Biotech Limited | Oral compositions for HIV-Infected Subjects |
EP1375651A3 (en) * | 2002-06-28 | 2004-01-07 | Ultra Biotech Limited | Oral compositions for white blood cell activation and proliferation |
US6984507B2 (en) | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of lung cancer |
US6984508B2 (en) | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of cervical cancer |
US6987012B2 (en) | 2003-06-11 | 2006-01-17 | Ultra Biotech Limited | Biological compositions and methods for treatment of colorectal cancer |
US6989253B2 (en) | 2003-06-11 | 2006-01-24 | Ultra Biotech Limited | Biological compositions and methods for treatment of testicular cancer |
US7201906B2 (en) | 2003-06-11 | 2007-04-10 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204987B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Biological compositions and methods for treatment of prostate cancer |
US7204988B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204986B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7208158B2 (en) | 2003-06-11 | 2007-04-24 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7214377B2 (en) | 2003-06-11 | 2007-05-08 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7220416B2 (en) | 2003-06-11 | 2007-05-22 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223404B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223405B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepareompositions comprising yeast treated with electromagnetic energy |
US7223400B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223401B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223403B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223402B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7226600B2 (en) | 2003-06-11 | 2007-06-05 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
WO2011023769A1 (en) * | 2009-08-26 | 2011-03-03 | Mb Milmed Ab | Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU902462A1 (en) * | 1980-03-26 | 1982-08-15 | Отдел Биологии Дагестанского Филиала Ан Ссср | Method for cultivating yeast |
SU1514777A1 (en) * | 1987-06-30 | 1989-10-15 | Inst Molekulyarnoj Biolog An S | Method of producing biomass of saccharomyces cerevisial yeast |
CN1185484A (en) * | 1996-12-11 | 1998-06-24 | 阿尔瓦罗·V·皮卡卢加 | Method for regulating cell conduction |
-
2001
- 2001-02-08 WO PCT/CN2001/000117 patent/WO2002062984A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU902462A1 (en) * | 1980-03-26 | 1982-08-15 | Отдел Биологии Дагестанского Филиала Ан Ссср | Method for cultivating yeast |
SU1514777A1 (en) * | 1987-06-30 | 1989-10-15 | Inst Molekulyarnoj Biolog An S | Method of producing biomass of saccharomyces cerevisial yeast |
CN1185484A (en) * | 1996-12-11 | 1998-06-24 | 阿尔瓦罗·V·皮卡卢加 | Method for regulating cell conduction |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1375652A3 (en) * | 2002-06-28 | 2004-01-07 | Ultra Biotech Limited | Oral compositions for HIV-Infected Subjects |
EP1375651A3 (en) * | 2002-06-28 | 2004-01-07 | Ultra Biotech Limited | Oral compositions for white blood cell activation and proliferation |
US6984507B2 (en) | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of lung cancer |
US6984508B2 (en) | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of cervical cancer |
US6987012B2 (en) | 2003-06-11 | 2006-01-17 | Ultra Biotech Limited | Biological compositions and methods for treatment of colorectal cancer |
US6989253B2 (en) | 2003-06-11 | 2006-01-24 | Ultra Biotech Limited | Biological compositions and methods for treatment of testicular cancer |
US7201906B2 (en) | 2003-06-11 | 2007-04-10 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204987B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Biological compositions and methods for treatment of prostate cancer |
US7204988B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204986B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7208158B2 (en) | 2003-06-11 | 2007-04-24 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7214377B2 (en) | 2003-06-11 | 2007-05-08 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7220416B2 (en) | 2003-06-11 | 2007-05-22 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223404B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223405B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepareompositions comprising yeast treated with electromagnetic energy |
US7223400B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223401B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223403B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223402B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7226600B2 (en) | 2003-06-11 | 2007-06-05 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
WO2011023769A1 (en) * | 2009-08-26 | 2011-03-03 | Mb Milmed Ab | Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast |
CN102481368A (en) * | 2009-08-26 | 2012-05-30 | 密美德有限公司 | Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast |
JP2013503138A (en) * | 2009-08-26 | 2013-01-31 | エムビー ミルメド エービー | Compositions, methods and uses for the treatment of neurodegenerative diseases or disorders comprising electromagnetic radiation yeast |
US9320768B2 (en) | 2009-08-26 | 2016-04-26 | Milmed Ab | Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002062984A1 (en) | The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof | |
Sampson | The evolution of the enablement and written description requirements under 35 USC § 112 in the area of biotechnology | |
WO2002062981A1 (en) | A yeast human immunoregulator and the method for preparing it | |
WO2002062983A1 (en) | A yeast with t cell immunoregulatory activity as well as the preparing method and the uses thereof | |
WO2002062985A1 (en) | A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof | |
Achilladelis et al. | The dynamics of technological innovation: the case of the pharmaceutical industry | |
Ge et al. | Screening and spontaneous mutation of pickle-derived Lactobacillus plantarum with overproduction of riboflavin, related mechanism, and food application | |
WO2002062982A1 (en) | A yeast having b cell immune regulation activity and its preparation method and application thereof | |
WO2005003168A3 (en) | Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies | |
AU2001260140A1 (en) | Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene. | |
EP4269561A3 (en) | Improved modalities for the treatment of degenerative diseases of the retina | |
WO1998019167A3 (en) | Cell stress regulated human mhc class i gene | |
WO2005046570A3 (en) | Human stem cell materials and methods | |
Li et al. | Investigation of Chlorella pyrenoidosa protein as a source of novel angiotensin I-converting enzyme (ACE) and dipeptidyl peptidase-IV (DPP-IV) inhibitory peptides | |
Sagu et al. | Comprehensive characterization and relative quantification of α-amylase/trypsin inhibitors from wheat cultivars by targeted HPLC-MS/MS | |
Mazloomi et al. | Impact of simulated gastrointestinal digestion on the biological activity of an alcalase hydrolysate of orange seed (Siavaraze, Citrus sinensis) by-products | |
Hu et al. | Purification and identification of novel xanthine oxidase inhibitory peptides derived from round scad (Decapterus maruadsi) protein hydrolysates | |
WO2005058945A3 (en) | Gene variants coding for proteins from the metabolic pathway of fine chemicals | |
WO2001053340A3 (en) | Transgenic mouse model of human neurodegenerative disease | |
Kęska et al. | Stability of antiradical activity of protein extracts and hydrolysates from dry-cured pork loins with probiotic strains of LAB | |
Luti et al. | Bioactive properties of breads made with sourdough of Hull-less barley or conventional and pigmented wheat flours | |
Karthivashan et al. | Comparative studies on behavioral, cognitive and biomolecular profiling of ICR, C57BL/6 and its sub-strains suitable for scopolamine-induced amnesic models | |
Liu et al. | Efficient hydrolysis of gluten-derived celiac disease-triggering immunogenic peptides by a bacterial serine protease from Burkholderia gladioli | |
Jang et al. | Antidiabetic, anticholesterol, and antioxidant activity of Gryllus bimaculatus fermented by Bacillus and Lactobacillus strains | |
Balli et al. | Millet Fermented by Different Combinations of Yeasts and Lactobacilli: Effects on Phenolic Composition, Starch, Mineral Content and Prebiotic Activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |